复杂冠状动脉病变西罗莫司洗脱支架置入后急性和亚急性支架内血栓形成情况分析Analysis of acute and subacute stent thrombosis after successful implantation of sirolimus-eluting stent in complex coronary lesions
宋现涛,陈韵岱,吕树铮,苑飞,金泽宁,田锐,陈欣,柳弘,孟康
摘要(Abstract)：
目的评价在真实临床环境下,对于复杂病变置入西罗莫司(雷帕霉素)洗脱支架后支架内急性、亚急性血栓的发生率。方法我院自2002年到2005年3月,连续有796名不同复杂冠状动脉(冠脉)病变的患者完全置入了西罗莫司洗脱支架(sirolimus-eluting stent,SES)。记录患者的一般临床特征和有否急性、亚急性血栓形成;所有患者平均临床随访6~9个月,随访期间对患者进行冠脉造影检查。结果(1)在796例患者中,有8例(1%,8/796)患者发生了经冠脉造影证实的急性/亚急性血栓,其中1例为急性支架内血栓形成,7例为亚急性支架内血栓形成;有1例临床高度怀疑为支架内亚急性血栓形成;(2)上述8例患者中有3例表现为急性ST段抬高的心肌梗死,4例表现为急性非ST段抬高的心肌梗死,1例表现为不稳定型心绞痛;1例高度怀疑支架内血栓形成的患者ECG表现为新发左束支传导阻滞;8例患者中有1例(12.5%,1/8)在30 d内死亡,其余7例患者给予积极治疗后6个月临床随访无不良心脏事件发生,6个月冠脉造影随访支架内没有发生再狭窄;(3)采用多因素逻辑回归分析结果显示分叉病变双支架置入及长病变支架置入是患者术后发生支架内血栓的危险因素,OR值分别为11.2和8.6,95%CI分别为4.1~30.8和1.9~17.2,P<0.001。结论在真实临床环境下,在没有经过严格入选标准筛选的复杂冠脉病变中置入SES支架后30 d内,支架内血栓的发生率在1%(8/796)左右,略高于文献报道的结果。分叉病变双支架及长病变支架是术后支架内发生血栓的高危因素。
关键词(KeyWords)： 血栓形成;支架;冠状动脉病变
基金项目(Foundation):
作者(Author): 宋现涛,陈韵岱,吕树铮,苑飞,金泽宁,田锐,陈欣,柳弘,孟康
参考文献(References)：
- [1]Schampaert E,Cohen EA,Schluter M,et al.The Canadian study ofthe sirolimus-eluting stent in the treatment of patients with longdenovo lesions in small native coronary arteries(C-SIRIUS).J AmColl Cardiol,2004,43:1110-1115.
- [2]Schofer J,Schluter M,Gershlick AH,et al.Sirolimus-eluting stentsfor treatment of patients with long atherosclerotic lesions in smallcoronary arteries:double-blind,randomized controlled trial(ESIRIUS).Lancet,2003,362:1093-1099.
- [3]Jeremias A,Sylvia B,Bridges J,et al.Stent thrombosis aftersuccessful sirolimus-eluting stent implantation.Circulation,2004,109:1930-1932.
- [4]Andrew TL,Hoye A,Aoki J,et al.Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal,sirolimus,or paclitaxel stent implantation.J Am Coll Cardiol,2005,45:947-953.
- [5]宋现涛,陈韵岱,吕树铮,等.真实临床环境下复杂冠状动脉病变雷帕霉素洗脱支架术后再狭窄影响因素评价.中华现代内科学杂志,2005,2:676-679.
- [6]Lemos PA,Lee CH,Degertekin M,et al.Early outcome aftersirolimus-eluting stent implantation in patients with acute coronarysyndromes:insights from the Rapamycin-Eluting Stent Evaluated AtRotterdam Cardiology Hospital(RESEARCH)registry.J Am CollCardiol,2003,41:2093-2099.
- [7]Raúl M,Cristina F,Rosana H,et al.Drug-eluting stent thrombosisresults from a pooled analysis including 10 randomized studies.J AmColl Cardiol,2005,45:954-959.
- [8]Ioannis IK,Thomas S,Erminio B,et al.Incidence,predictors,andoutcome of thrombosis after successful implantation of drug-elutingstents.JAMA,2005,293:2126-2130.
- [9]Lei G,Flavio A,Ioannis IK,et al.Clinical and angiographicoutcome after implantation of drug-eluting stents in bifurcation lesionswith the crush stent technique.J Am Coll Cardiol,2005,46:613-620.
- [10]Cutlip DE,Baim DS,Ho KKL,et al.Stent thrombosis in themodern era:A pooled analysis of multicenter coronary stent clinicaltrials.Circulation,2001,103:1967-1971.
- [11]Chieffo A,Bonizzoni E,Orlic D,et al.Intraprocedural stentthrombosis during implantation of sirolimus-eluting stents.Circulation,2004,109:2732-2736.